Search for a clinical trial
Other search option(s)
9 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
; Member of a ERN = 
National clinical trial(s)
FRANCE
AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR
A randomized, double-blind, double-dummy active-comparator, multicenter study to evaluate the efficacy and safety of rituximab versus MMF in patients with pemphigus vulgaris -FR
Institution: Information not provided - FR
FRANCE
NOUVELLE AQUITAINE
BORDEAUX
PEMPA : Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid (Phase III)
CHU de Bordeaux - Hôpital Saint André
Service de Dermatologie adulte et pédiatrique
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
ADDRESS+: An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients with Pemphigus - DE
Institution: Information not provided - DE
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
ADDRESS: A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus) - DE
Institution: Information not provided - DE
GERMANY
Hessen
MARBURG
TPV11: A multi-centre, open-label, phase 1 study, Part A single ascending dose and Part B multiple dose, to evaluate the safety, tolerability and pharmacokinetics, and to explore early signs of effectiveness of induction of antigen-specific immune tolerance with TPM203 in pemphigus vulgaris patients (PEGASUS: SP 8)
Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg
Klinik für Dermatologie und Allergologie
SPAIN
Galicia
SANTIAGO DE COMPOSTELA
A Long-Term Follow-up Study to Evaluate the Safety and Efficacy of Adeno-Associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Glucose-6-Phosphatase (G6Pase) in Adults with Glycogen Storage Disease Type Ia (GSDIa) - ES
Hospital Clínico Universitario de Santiago
Servicio de Pediatría
SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES
ADDRESS+: An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1905 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus (ADDRESS PLUS) - ARGX-113-1905 - ES
Institution: Information not provided - ES
SPAIN
Madrid
ADDRESS: NOT PROVIDED - ES
ADDRESS: A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus) - ES
Institution: Information not provided - ES
Multinational clinical trial(s)
UNITED STATES
California
SOUTH SAN FRANCISCO